Ascopiave S.p.A.
ASCOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $614 | $612 | $670 | $703 |
| - Cash | $25 | $59 | $36 | $34 |
| + Debt | $661 | $652 | $406 | $426 |
| Enterprise Value | $1,251 | $1,205 | $1,040 | $1,094 |
| Revenue | $76 | $53 | $55 | $59 |
| % Growth | 42.9% | -3% | -6.6% | – |
| Gross Profit | $70 | $49 | $54 | $55 |
| % Margin | 91.6% | 91.7% | 98.5% | 93.7% |
| EBITDA | $38 | $74 | $29 | $31 |
| % Margin | 49.5% | 139.6% | 52.5% | 52.3% |
| Net Income | $11 | $56 | $9 | $10 |
| % Margin | 14.2% | 105% | 16.9% | 17.2% |
| EPS Diluted | 0.05 | 0.26 | 0.043 | 0.047 |
| % Growth | -80.8% | 506.1% | -8.1% | – |
| Operating Cash Flow | $14 | $14 | $37 | $47 |
| Capital Expenditures | -$25 | -$20 | -$15 | -$29 |
| Free Cash Flow | -$11 | -$6 | $21 | $17 |